ABL Bio Market Cap

ABL Bio has a market cap or net worth of 5.95 trillion as of May 20, 2026. Its market cap has increased by 78.52% in one year.

Market Cap

5.95T

Enterprise Value

5.89T

Revenue

79.35B

Ranking

n/a

PE Ratio

n/a

Stock Price

106,300.00

Market Cap Chart

Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 5.95T, an increase of 877.87%. That is a compound annual growth rate of 35.96%.

Market Cap History

Date	Market Cap	% Change
May 20, 2026	5.95T	-46.02%
Dec 30, 2025	11.03T	663.70%
Dec 30, 2024	1.44T	22.53%
Dec 28, 2023	1.18T	7.19%
Dec 29, 2022	1.10T	5.54%
Dec 30, 2021	1.04T	-27.59%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 19, 2018	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	64.16T
Celltrion	38.40T
ALTEOGEN	19.13T
Samsung Epis Holdings	12.35T
Sam Chun Dang Pharm.	8.69T
SK Biopharmaceuticals	7.48T
HLB Co., Ltd.	6.68T
Yuhan	6.19T

Market Cap Rankings